for maintaing health though gut integrity
Find Out More
Midway Pharmaceuticals, Inc., is initially developing a proprietary daily dietary supplement to enhance bone health in post-menopausal women. In addition to calcium and vitamin D, Midway’s product contains components that affect interactions between the gastrointestinal tract (or gut) and gut bacterial populations (the Microbiome).
Gut bacteria and their products have been recently found to affect bone health when estrogen levels decrease. Taken orally, our products will help maintain healthy gut barrier integrity and block the effects of pathogenic bacteria that lead to bone loss.
Midway Pharmaceuticals is a privately-held specialty company located in Philadelphia. Midway was founded by gastrointestinal scientists at the University of Chicago in the Departments of Surgery, Digestive Diseases, Infectious Disease and an experienced gastroenterologist and biotech entrepreneur. The initial observations leading to products to maintaining health through gut integrity was extended by a scientist in bone physiology at Michigan State University in collaboration with Midway.
Midway is focused on developing proprietary agents for enhancing health and wellness in people suffering gastrointestinal and systemic disorders. Gut bacteria are increasing thought to influence bone density, obesity, inflammatory bowel disease, irritable bowel syndrome, radiation injury to the gut during cancer therapy, neonatal necrotizing enterocolitis in premature infants, gut bacteria-derived sepsis. And the list keeps growing yearly
We can be reached at: